These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24060536)

  • 1. A real-time killing assay to follow viral epitope presentation to CD8 T cells.
    Gourdain P; Boucau J; Kourjian G; Lai NY; Duong E; Le Gall S
    J Immunol Methods; 2013 Dec; 398-399():60-7. PubMed ID: 24060536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Activation State of CD4 T Cells Alters Cellular Peptidase Activities, HIV Antigen Processing, and MHC Class I Presentation in a Sequence-Dependent Manner.
    Boucau J; Madouasse J; Kourjian G; Carlin CS; Wambua D; Berberich MJ; Le Gall S
    J Immunol; 2019 May; 202(10):2856-2872. PubMed ID: 30936293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
    Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K
    J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential HIV epitope processing in monocytes and CD4 T cells affects cytotoxic T lymphocyte recognition.
    Lazaro E; Godfrey SB; Stamegna P; Ogbechie T; Kerrigan C; Zhang M; Walker BD; Le Gall S
    J Infect Dis; 2009 Jul; 200(2):236-43. PubMed ID: 19505257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.
    Brander C; Yang OO; Jones NG; Lee Y; Goulder P; Johnson RP; Trocha A; Colbert D; Hay C; Buchbinder S; Bergmann CC; Zweerink HJ; Wolinsky S; Blattner WA; Kalams SA; Walker BD
    J Virol; 1999 Dec; 73(12):10191-8. PubMed ID: 10559335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ T cells from HIV-1-infected patients recognize wild-type and mutant human immunodeficiency virus-1 protease epitopes.
    Muller NG; Alencar R; Jamal L; Hammer J; Sidney J; Sette A; Brindeiro RM; Kalil J; Cunha-Neto E; Moraes SL
    Clin Exp Immunol; 2011 Apr; 164(1):90-9. PubMed ID: 21352200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
    Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence-specific alterations of epitope production by HIV protease inhibitors.
    Kourjian G; Xu Y; Mondesire-Crump I; Shimada M; Gourdain P; Le Gall S
    J Immunol; 2014 Apr; 192(8):3496-506. PubMed ID: 24616479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen Production After Latency Reversal and Expression of Inhibitory Receptors in CD8+ T Cells Limit the Killing of HIV-1 Reactivated Cells.
    Ruiz A; Blanch-Lombarte O; Jimenez-Moyano E; Ouchi D; Mothe B; Peña R; Galvez C; Genescà M; Martinez-Picado J; Goulder P; Barnard R; Howell B; Clotet B; Prado JG
    Front Immunol; 2018; 9():3162. PubMed ID: 30723480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocyte cross-recognition may explain the immune reaction in infected individuals.
    Thorn M; Tang S; Therrien D; Kløverpris H; Vinner L; Kronborg G; Gerstoft J; Corbet S; Fomsgaard A
    APMIS; 2007 Jun; 115(6):757-68. PubMed ID: 17550385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response.
    Jones NA; Wei X; Flower DR; Wong M; Michor F; Saag MS; Hahn BH; Nowak MA; Shaw GM; Borrow P
    J Exp Med; 2004 Nov; 200(10):1243-56. PubMed ID: 15545352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nef Is Dispensable for Resistance of Simian Immunodeficiency Virus-Infected Macrophages to CD8+ T Cell Killing.
    Rainho JN; Martins MA; Cunyat F; Watkins IT; Watkins DI; Stevenson M
    J Virol; 2015 Oct; 89(20):10625-36. PubMed ID: 26269172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective lysis of HIV-1-infected primary CD4+ T cells by a cytotoxic T-lymphocyte clone directed against a novel A2-restricted reverse-transcriptase epitope.
    Shankar P; Sprang H; Lieberman J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct; 19(2):111-20. PubMed ID: 9768618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Immunodominant HIV-1 Epitopes Presented by HLA-C*12:02, a Protective Allele, Using an Immunopeptidomics Approach.
    Chikata T; Paes W; Akahoshi T; Partridge T; Murakoshi H; Gatanaga H; Ternette N; Oka S; Borrow P; Takiguchi M
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31217245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.
    Le Borgne S; Février M; Callebaut C; Lee SP; Rivière Y
    J Virol; 2000 May; 74(10):4456-64. PubMed ID: 10775581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SAMHD1 Limits HIV-1 Antigen Presentation by Monocyte-Derived Dendritic Cells.
    Ayinde D; Bruel T; Cardinaud S; Porrot F; Prado JG; Moris A; Schwartz O
    J Virol; 2015 Jul; 89(14):6994-7006. PubMed ID: 25926647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II.
    SenGupta D; Norris PJ; Suscovich TJ; Hassan-Zahraee M; Moffett HF; Trocha A; Draenert R; Goulder PJ; Binder RJ; Levey DL; Walker BD; Srivastava PK; Brander C
    J Immunol; 2004 Aug; 173(3):1987-93. PubMed ID: 15265933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latency reversal agents modulate HIV antigen processing and presentation to CD8 T cells.
    Boucau J; Das J; Joshi N; Le Gall S
    PLoS Pathog; 2020 Mar; 16(3):e1008442. PubMed ID: 32196533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-12 is necessary for the priming of CD4+ T cells required during the elicitation of HIV-1 gp120-specific cytotoxic T-lymphocyte function.
    Gupta S; Boppana R; Mishra GC; Saha B; Mitra D
    Immunology; 2008 Aug; 124(4):553-61. PubMed ID: 18298551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.